{"id":50542,"date":"2022-11-07T14:02:41","date_gmt":"2022-11-07T13:02:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/"},"modified":"2022-11-07T14:02:41","modified_gmt":"2022-11-07T13:02:41","slug":"aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/","title":{"rendered":"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch"},"content":{"rendered":"
\n

\nOfficial US rollout kicks off with coveted award from Cosmopolitan Magazine and new $99\/month* patient financing options<\/i>\n<\/p>\n

BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America. AviClear is the first and only energy device to be both FDA cleared and Health Canada approved for the treatment of mild, moderate, and severe acne, with additional approval in Canada for acne scars.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nAviClear has seen widespread interest from physicians and patients following its FDA clearance in March 2022, and was recently awarded the \u201cBest Laser Treatment for Acne\u201d by Cosmopolitan Magazine<\/i>. In conjunction with greater availability, Cutera is also announcing a new, monthly financing plan to US consumers starting at $99 a month*.\n<\/p>\n

\n\u201cI was an early AviClear adopter because I know this treatment will change the way my acne patients face the world,\u201d said Sonia Batra, MD, founder of Batra Dermatology. \u201cI am thrilled my colleagues nationwide will now have access to this device, and I am even happier for their patients who have not wanted or could not proceed with prescription options. What makes the treatment even more appealing is that it can be used on all skin types and acne severities without adverse effects. I have no doubt it will be the treatment of choice for many acne sufferers.\u201d\n<\/p>\n

\n\u201cWe are pleased to see AviClear praised as a groundbreaking treatment by physicians, patients, and the media,\u201d said Dave Mowry, CEO of Cutera. \u201cPairing the commercial launch with the new patient financing option will enable us to extend the reach of AviClear to more people who want an effective, chemical-free, and durable solution to their acne.\n<\/p>\n

\n\u201cBased on our market feedback to date, we are confident that patient demand and practice installations will continue to grow over the next several quarters beginning in the first quarter of 2023,\u201d said Mowry. \u201cAffordability, efficacy, and durability will help establish AviClear as the gold standard of care for acne suffers.\u201d\n<\/p>\n

\nAviClear is now broadly available to physicians and practitioners across the United States, with a limited commercial release in Canada. Doctors and patients are encouraged to visit www.AviClear.com<\/a> to find out more information.\n<\/p>\n

\nAbout Cutera, Inc.<\/b>\n<\/p>\n

\nBrisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1 415-657-5500 or 1-888-4CUTERA or visit www.cutera.com<\/a>.\n<\/p>\n

\n*Terms and conditions apply.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPR Contact:
\n
EvolveMKD, Cutera@EvolveMKD.com<\/a>\n<\/p>\n

\nInvestor Relations:
\n
Greg Barker, VP of FP & A \u2013 IR@cutera.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Official US rollout kicks off with coveted award from Cosmopolitan Magazine and new $99\/month* patient financing options BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America. AviClear is the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50542","6":"format-standard","7":"category-industry"},"yoast_head":"\nAviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Official US rollout kicks off with coveted award from Cosmopolitan Magazine and new $99\/month* patient financing options BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America. AviClear is the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-07T13:02:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221107005473\/en\/1627187\/21\/AviClear_National_Press_Release_Image.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch\",\"datePublished\":\"2022-11-07T13:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/\"},\"wordCount\":475,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221107005473\\\/en\\\/1627187\\\/21\\\/AviClear_National_Press_Release_Image.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/\",\"name\":\"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221107005473\\\/en\\\/1627187\\\/21\\\/AviClear_National_Press_Release_Image.jpg\",\"datePublished\":\"2022-11-07T13:02:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221107005473\\\/en\\\/1627187\\\/21\\\/AviClear_National_Press_Release_Image.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221107005473\\\/en\\\/1627187\\\/21\\\/AviClear_National_Press_Release_Image.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/","og_locale":"en_US","og_type":"article","og_title":"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch - Pharma Trend","og_description":"Official US rollout kicks off with coveted award from Cosmopolitan Magazine and new $99\/month* patient financing options BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announces that AviClear is now broadly available to physicians and practitioners treating patients throughout North America. AviClear is the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-07T13:02:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221107005473\/en\/1627187\/21\/AviClear_National_Press_Release_Image.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch","datePublished":"2022-11-07T13:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/"},"wordCount":475,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221107005473\/en\/1627187\/21\/AviClear_National_Press_Release_Image.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/","url":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/","name":"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221107005473\/en\/1627187\/21\/AviClear_National_Press_Release_Image.jpg","datePublished":"2022-11-07T13:02:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221107005473\/en\/1627187\/21\/AviClear_National_Press_Release_Image.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221107005473\/en\/1627187\/21\/AviClear_National_Press_Release_Image.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AviClear\u2122 Now Broadly Available to US Physicians and Practitioners Upon National Launch"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50542"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50542\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}